Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about AZN

Recent news which mentions AZN

...

26 27 28 29 30 31 32 33 Next >

Why Shares of Vaxart Jumped 31.2% in the First Half of 2021

July 19, 2021

2 Compelling Reasons to Buy This Reawakened Pharma Giant

July 19, 2021

U.K. drops COVID restrictions against advice of experts, and delta variant drives cases higher across the U.S.

July 19, 2021

Aridis In-Licenses Pneumonia Candidate From AstraZeneca

July 19, 2021

China Approves AstraZeneca's Imfinzi For Extensive-Stage Small Cell Lung Cancer

July 19, 2021

AstraZeneca's Acquisition of Alexion Is Nearly a Done Deal, But Is It a Good Deal?

July 17, 2021

With the Alexion Acquisition Set to Close This Quarter, Is AstraZeneca a Buy?

July 17, 2021

What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.

July 16, 2021

Jon Najarian Sees Unusual Options Activity In AstraZeneca And Home Depot

July 16, 2021

Ericsson inks its largest-ever deal with Verizon in $8.3 billion 5G plan as it faces headwinds from China

July 16, 2021

This Nasdaq Vaccine Stock Just Got a Big Boost -- and Another Nasdaq Vaccine Stock Deserves the Credit

July 16, 2021

COVID-19 cases are now rising in all 50 states, as global tally tops 189 million

July 16, 2021

Unusual Options Activity Insight: AstraZeneca

July 16, 2021

Why Moderna Stock Just Jumped 10%

July 16, 2021

MRNA Stock: 10 Things to Know About Moderna as It Gets Ready to Join the S&P 500

July 16, 2021

Burberry, Rio Tinto and AstraZeneca keep a lid on London stock gains

July 16, 2021

GlaxoSmithKline's Anemia Candidate Shows Promise In Late-Stage Studies

July 16, 2021

Why Moderna Shares Are Rallying Today

July 16, 2021

FibroGen Staring At Multi-Year Lows Following Adverse Roxadustat AdCom Verdict; How Hard Will The Stock Likely Fall?

July 16, 2021

3 Things About Novavax That Smart Investors Know

July 16, 2021

Moderna set to join S&P 500, stock rallies 8%

July 15, 2021

Understanding AstraZeneca's Unusual Options Activity

July 15, 2021

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs

July 15, 2021

What 3 FibroGen Analysts Are Expecting From Thursday's Roxadustat Adcom Verdict

July 14, 2021

EU Regulator Weighing Mix-And-Match, Boosters For COVID-19 Shots

July 14, 2021

Unusual Options Activity Insight: AstraZeneca

July 14, 2021

Delta variant drove COVID-19 cases higher across the globe last week — including in the U.S.

July 14, 2021

AstraZeneca, JNJ To Start Research On Potentially Modified COVID-19 Shots: WSJ

July 13, 2021

Ahead Of AdComm AstraZeneca, FibroGen's Roxadustat Hit With Safety, Efficacy Questions

July 13, 2021

Here’s why just allowing an ‘exit wave’ of COVID-19 cases carries huge risks for countries

July 13, 2021

...

26 27 28 29 30 31 32 33 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.